Merck KGaA and Dr Reddy’s to collaborate on biosimilar mAbs
05:18 EDT 8 Jun 2012 | GaBI online
Pharma major Merck KGaA announced on 6 June 2012 its first steps into the biosimilars market, with an agreement with India-based generics manufacturer Dr Reddy’s Laboratories (Dr Reddy’s) to co-develop biosimilar cancer drugs.
Original Article: Merck KGaA and Dr Reddy’s to collaborate on biosimilar mAbs
More From BioPortfolio on "Merck KGaA and Dr Reddy’s to collaborate on biosimilar mAbs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
